Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

Objective: To evaluate the efficacy and tolerability of anti-tumour necrosis factor α (TNFα) monoclonal antibody (infliximab) in the treatment of spondyloarthropathy (SpA) associated with active and inactive Crohn's disease (CD). Methods: Twenty four patients with SpA associated with active or...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Generini, S, Giacomelli, R, Fedi, R, Fulminis, A, Pignone, A, Frieri, G, Del Rosso, A, Viscido, A, Galletti, B, Fazzi, M, Tonelli, F, Matucci-Cerinic, M
Format:	Artigo
Sprog:	Inglês
Udgivet:	2004
Fag:	Extended Report
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC1754868/ https://ncbi.nlm.nih.gov/pubmed/15297279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.012450
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

Lignende værker